$AMGN Recent News Facebook, Gilead shares fall after

New Post Public Reply Private Reply Replies (0) Message Board

Nov 1, 2014 at 11:31 AM

$AMGN Recent News

Facebook, Gilead shares fall after hours 6:14 p.m. Oct. 28, 2014 - Sue Chang
Amgen, under investor pressure, outlines strategy 10:05 a.m. Oct. 28, 2014 - MarketWatch.com
Amgen's stock rises after company outlines capital allocation plans 9:07 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen's stock climbs 3.2% in premarket trade after capital allocation plans 8:55 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen sees 2015 revenue $20.8 bln-$21.3 bln vs. FactSet consensus $20.33 bln 8:54 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen sees 2015 adj. EPS $9.05-$9.40 vs. FactSet consensus $9.08 8:53 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen plans to payout 60% of adj. earnings to shareholders through 2018 8:52 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen plans to raise dividend 30% starting in Q1 2015 8:52 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen resumes share buybacks, with plans for $2 bln in repurchases through 2015 8:51 a.m. Oct. 28, 2014 - Tomi Kilgore
‘Dumb money’ unloads bullish oil bets as prices pose threat to stocks 8:35 a.m. Oct. 28, 2014 - Shawn Langlois
4 more ‘Amazon’ stocks you may want to avoid 8:43 p.m. Oct. 27, 2014 - Philip van Doorn
Newscast: Stocks mixed -- barely 6:46 p.m. Oct. 27, 2014 - MarketWatch
Twitter shares drop in wake of quarterly results 5:07 p.m. Oct. 27, 2014 - Sue Chang
Amgen posts strong results on higher sales 4:57 p.m. Oct. 27, 2014 - MarketWatch.com
Updates, advisories and surprises 4:31 p.m. Oct. 27, 2014 - MarketWatch
Amgen net drops, but adjusted earnings beat views 4:14 p.m. Oct. 27, 2014 - Russ Britt
Amgen GAAP net of $1.61 is below $1.81 view 4:06 p.m. Oct. 27, 2014 - Russ Britt
Amgen adj. net of $2.30 beats views of $2.11 4:05 p.m. Oct. 27, 2014 - Russ Britt
Amgen shares rise 1.9% following Q3 earnings release 4:04 p.m. Oct. 27, 2014 - Sue Chang
Amgen Q3 revenue is $5.03B vs. last year's $4.75B 4:04 p.m. Oct. 27, 2014 - Russ Britt

The Untouchables: Where Even Activist Investors Fear to Tread 2:58 p.m. Oct. 31, 2014 - TheStreet.com
AbbVie Beats Q3 Earnings Estimates, Raises Guidance 1:25 p.m. Oct. 31, 2014 - Investors Business Daily
Aegerion Q3 Loss Wider than Expected, 2014 View Lowered - Analyst Blog 11:32 a.m. Oct. 31, 2014 - Zacks.com
Amgen (AMGN) Hits New Lifetime High 9:47 a.m. Oct. 31, 2014 - TheStreet.com
United Therapeutics Sells Off On Good News - Why I Bought That Dip 3:52 p.m. Oct. 30, 2014 - Seeking Alpha
3 Stocks Reiterated As A Buy: AIG, GS, AMGN 3:14 p.m. Oct. 30, 2014 - TheStreet.com
Amgen Continues To Offer The Best Value In Biotech 9:23 a.m. Oct. 30, 2014 - Seeking Alpha
Amgen: Great News Sends Shares To Fresh All-Time Highs 8:50 a.m. Oct. 30, 2014 - Seeking Alpha
Top Health Care and Biotech Stocks to Buy That Have Already Posted Earnings 8:21 a.m. Oct. 30, 2014 - 247WallSt.com
Buy These Top Ranked ETFs on Solid Biotech Stock Earnings - ETF News And Commentary 8:00 a.m. Oct. 30, 2014 - Zacks.com
10-Q: AMGEN INC 4:49 p.m. Oct. 29, 2014 - Edgar Online - (EDG = 10Q, 10K)
Amgen Up on Strategic Initiatives and 2015 Guidance - Analyst Blog 3:05 p.m. Oct. 29, 2014 - Zacks.com
Ligand Pharmaceuticals' Shares Fall on Q3 Earnings Miss - Analyst Blog 2:00 p.m. Oct. 29, 2014 - Zacks.com
Biotech Stock Roundup: Beat & Raise Quarter for Amgen, Celgene, Alexion, Biogen - Analyst Blog 12:28 p.m. Oct. 29, 2014 - Zacks.com
3 Health Care Picks To Beat Earnings - Earnings ESP 12:09 p.m. Oct. 29, 2014 - Zacks.com
Ligand Pharmaceuticals Has Rich A Valuation Now But Is Undervalued For Long Term Success 11:34 a.m. Oct. 29, 2014 - Seeking Alpha
UPDATE: Nomura Upgrades Amgen 10:42 a.m. Oct. 29, 2014 - benzinga.com
Stock Market News for October 29, 2014 - Market News 10:10 a.m. Oct. 29, 2014 - Zacks.com
Analysts' Actions: Alibaba, Amazon.com, eBay, Cliffs Natural, More 8:50 a.m. Oct. 29, 2014 - TheStreet.com
Top Analyst Upgrades and Downgrades: Alibaba, Amgen, Cliffs, Michael Kors, Sanofi, Yahoo! and More 8:28 a.m. Oct. 29, 2014 - 247WallSt.com

Financial Results, Program Expansion, Product Launch, and Share Dealings - Research Reports on Merck, Johnson & Johnson, Amgen, Medtronic and Shire 9:15 a.m. Oct. 30, 2014 - PR Newswire - PRF
Xencor Renegotiates XmAb®5871 Agreement with Amgen; Regains All Rights and Plans Clinical Development in Rare Autoimmune Disease 4:00 p.m. Oct. 28, 2014 - PR Newswire - PRF
Amgen Outlines Strategy, Growth Objectives And Capital Allocation Plans 8:48 a.m. Oct. 28, 2014 - PR Newswire - PRF
Global and China Monoclonal Antibody Industry Report, 2014-2019 9:26 p.m. Oct. 27, 2014 - PR Newswire - PRF
Amgen's Third Quarter 2014 Revenues Increased 6 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 19 Percent To $2.30 4:01 p.m. Oct. 27, 2014 - PR Newswire - PRF
Amgen To Webcast 2014 Business Review Meeting On October 28 5:39 p.m. Oct. 23, 2014 - PR Newswire - PRF
Global Pediatric Drugs and Vaccines Market 5:08 p.m. Oct. 23, 2014 - PR Newswire - PRF
Amgen Announces Webcast of 2014 Third Quarter Financial Results 4:05 p.m. Oct. 23, 2014 - PR Newswire - PRF
Global & USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) 5:59 p.m. Oct. 22, 2014 - PR Newswire - PRF
Global & USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) 5:54 p.m. Oct. 22, 2014 - PR Newswire - PRF
Amgen Statement Regarding Third Point Investment 3:41 p.m. Oct. 21, 2014 - PR Newswire - PRF
Merger Deal Updates, Dividend, Dispute Settlement, Regulatory Application Submission, and Preliminary Results - Research Reports on Shire, Johnson & Johnson, Merck, Amgen and HCA 9:00 a.m. Oct. 21, 2014 - PR Newswire - PRF
Analyst Scanner on Biotech Equities - Amgen, Exelixis, Regeneron Pharma, Lexicon Pharma, and BioMarin Pharma 9:00 a.m. Oct. 20, 2014 - PR Newswire - PRF
Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors 4:17 p.m. Oct. 17, 2014 - PR Newswire - PRF
Amgen Announces 2014 Fourth Quarter Dividend 4:03 p.m. Oct. 17, 2014 - PR Newswire - PRF
Amgen Files Lawsuit Against Sanofi And Regeneron For Patent Infringement 9:00 a.m. Oct. 17, 2014 - PR Newswire - PRF
Alirocumab (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023 6:40 p.m. Oct. 14, 2014 - PR Newswire - PRF
Welfare Initiatives, Clinical Data Presentation, Financing Plan, Regulatory Disclosure, and Positive Drug Trials - Research Reports on Johnson & Johnson, Merck, Medtronic, Covidien and Amgen 8:35 a.m. Oct. 13, 2014 - PR Newswire - PRF
Amgen's BiTE® Immunotherapy Blinatumomab Receives FDA Priority Review Designation In Acute Lymphoblastic Leukemia 4:05 p.m. Oct. 9, 2014 - PR Newswire - PRF
Amgen Announces Positive Top-Line Results From Phase 3 Study Evaluating The Efficacy And Safety Of Biosimilar Candidate ABP 501 Compared With Adalimumab In Patients With Moderate-To-Severe Plaque Psoriasis 9:15 a.m. Oct. 8, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

S?LACE Boats Unveils First Catamaran, the 41CT

Setting a New Course with the 41CT Picture this: a company known for pushing the envelope does it again, but this time, they aren't just elbowing their way into the catamaran market—they're redefining it. S?LACE Boats has unveiled their all-new 41CT center console catamaran. Not just another addition, it's practically a game-changer for anyone passionate about offshore...

Beta Bionics Hit with Lawsuit Over Misleading Claims

Unpacking Beta Bionics' Legal Storm Investors in Beta Bionics, Inc. —ticker BBNX—are probably feeling like they're caught in a whirlwind right now, and who can blame them? The company's facing a class action lawsuit, and the accusations aren't anything to sniff at. They're talking about violations of the Securities Exchange Act of 1934, along with some shady...

FirstService Ups the Ante with Stylish Jacksonville Office

A New Chapter for FirstService Residential Picture this: a property management powerhouse dialing up their Jacksonville operations with a shiny new office move. FirstService Residential, North America's big shot in property management, has swapped location to a swish setup on Southpoint Drive South in Jacksonville, Florida, aiming to supercharge collaboration and give a...

3D Concrete Printing Set to Transform Construction by 2035

Concrete Revolution: The 3D Printing Surge Times are changing in construction, and this ain’t your grandfather’s cinder block. We're talking about 3D concrete printing here—an industry poised to swell from just a pipedream sort of $293.4 million in 2025 to a staggering $1.87 billion by 2035. Driven by housing demands and resilient defense contracts, the sector is...

Decoding New Loyalty Strategies with TrueLoyal In this cutthroat market, loyalty's the name of the game, and TrueLoyal just rolled out a sharp new tool that's got me raising an eyebrow. Their Advanced Analytics is shaking up the way brands look at their loyalty programs. This ain't your granddad's analytics tool—it promises to cut the fat and put your spending where it...

b.well and MyDirectives Streamline Access to Care Plans

Pioneering Access to Critical Care Documents Ever thought about where all those critical healthcare documents are stashed? Trust me, it’s often a mess—file cabinets, bookshelves, or stuck in some forgotten safety deposit box. Well, b.well Connected Health and MyDirectives are rolling up their sleeves to change that. They've teamed up to make advance care planning...

New Blood Joins Board: A Power Move for Bank of America

A Fresh Breeze in the Boardroom Bank of America isn't sitting still. They're shaking things up by bringing in Jim Fitterling and Bill Thomas. Now, why’s that a big deal for those watching NYSE:BAC? Well, these guys pack heavy resumes, and their experience could steer the ship with precision across turbulent financial waters. The Minds Behind the Names Let's chew the fat...

Labcorp Scoops Up BioReference Health For $722M+

Picture this: You’re a big fish like Labcorp ready to feast on smaller catches. That’s exactly what’s rolling out as OPKO Health cuts a deal to offload a chunk of its BioReference Health assets to Labcorp for a tidy $722 million in cash. Assets on the Move OPKO’s BioReference Health has long been a player in the clinical testing world, with a focus on services...

EverSmith Rolls Out Training Hub to Propel Franchise Growth

Big Ambitions Nestled in Milford, Ohio Beneath the glow of fluorescent lights in a fresh-to-the-world 12,000-square-foot box of opportunity, EverSmith Brands is betting on big returns. EverHUB has opened its doors, aiming to be the cradle that hatches their aggressive franchise dreams into reality. It's not just brick and mortar—it’s the manifestation of their grand...

Baltimore's New Pact for Family Financial Stability

An Ambitious Proposal for Baltimore's Future Folks, of all places, Baltimore is making waves in the realm of direct financial support again. Being a city that's no stranger to economic challenges, it’s doubling down on an approach that’s shown actual promise. Enter the new partnership between the CASH Campaign of Maryland and Baltimore City. They’re set to shape...